Neurology Central

Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson’s diagnosis and prognosis


Since diagnosis of Parkinson’s disease (PD) is mostly based on clinical criteria, it is almost impossible to formulate an early diagnosis, as well as a timely differential diagnosis versus other parkinsonisms. A great effort in searching reliable biomarkers both for early diagnosis and prognosis in PD is currently ongoing. Cerebrospinal fluid has been widely investigated as potential source for such biomarkers, with particular emphasis on α-synuclein (α-syn) species.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.